CYCC - Cyclacel Pharmaceuticals GAAP EPS of -$2.27 beats by $2.48
2024-05-14 16:53:41 ET
More on Cyclacel Pharmaceuticals
- Cyclacel Pharmaceuticals, Inc. (CYCC) Q4 2023 Earnings Call Transcript
- Cyclacel Pharmaceuticals GAAP EPS of -$6.23 misses by $0.34
- Cyclacel Pharmaceuticals receives $2.9M R&D tax credit
- Seeking Alpha’s Quant Rating on Cyclacel Pharmaceuticals
- Historical earnings data for Cyclacel Pharmaceuticals